Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function

被引：10
|
作者：
Dureau, G [1 ]
Obadia, JF [1 ]
Chuzel, M [1 ]
Boissonnat, P [1 ]
机构：
[1] Hop Cardiol, F-69437 Lyon, France
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 02期
关键词：
D O I：
10.1016/S0041-1345(00)00817-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [1] Introduction of mycophenolate mofetil (MMF) and ciclosporine (CSA) withdrawal in heart transplant patients with progressive deteriorating renal function
    Dureau, G
    Obadia, JF
    Chuzel, M
    Boissonnat, P
    TRANSPLANTATION, 1999, 67 (07) : S24 - S24
  • [2] Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone
    ter Meulen, CG
    Gregoor, PJHS
    Weimar, W
    Hilbrands, LB
    TRANSPLANT INTERNATIONAL, 2001, 14 (02) : 99 - 102
  • [3] Withdrawal of mycophenolate mofetil in stable renal transplant patients
    Kaplan, B
    Meier-Kriesche, HU
    Friedman, G
    Mulgaonkar, S
    Vaghela, M
    Duva, D
    Nittoly, M
    Jacobs, M
    TRANSPLANTATION, 1999, 67 (07) : S116 - S116
  • [4] Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients
    Schrama, YC
    Joles, JA
    van Tol, A
    Boer, P
    Koomans, HA
    Hené, RJ
    TRANSPLANTATION, 2000, 69 (03) : 376 - 383
  • [5] Withdrawal of cyclosporine or prednisone in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone;: A randomised study
    de Sévaux, RGL
    Gregoor, PJHS
    Hené, RJ
    Weimar, W
    Hoitsma, AJ
    Ligtenberg, G
    van Gelder, T
    Hilbrands, LB
    TRANSPLANTATION, 1999, 67 (07) : S240 - S240
  • [6] Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine
    Baryalei, M
    Zenker, D
    Pieske, B
    Tondo, K
    Dalichau, H
    Aleksic, I
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1539 - 1542
  • [7] MYCOPHENOLATE MOFETIL IN IGA NEPHROPATHY WITH DETERIORATING RENAL FUNCTION
    Merida, Evangelina
    Huerta, Ana
    Gutierrez, Eduardo
    Hernandez, Eduardo
    Sevillano, Angel
    Caro, Jara
    Cavero, Teresa
    Morales, Enrique
    Antonio Moreno, Jose
    Praga, Manuel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 200 - 200
  • [8] Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
    Thervet, E
    Morelon, E
    Ducloux, D
    Bererhi, L
    Noël, LH
    Bedrossian, JJ
    Puget, S
    Chalopin, JM
    Mihatsch, M
    Legendre, C
    Kreis, H
    CLINICAL TRANSPLANTATION, 2000, 14 (06) : 561 - 566
  • [9] Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients
    Kato, Yojiro
    Tojimbara, Tamotsu
    Iwadoh, Kazuhiro
    Koyama, Ichiro
    Nanmoku, Koji
    Kai, Kotaro
    Sannomiya, Akihito
    Nakajima, Ichiro
    Fuchinoue, Shohei
    Teraoka, Satoshi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (13-14) : 1984 - 1992
  • [10] The addition of mycophenolate mofetil to low-dose cyclosporine A-based immunosupression improves renal function in heart transplant patients
    Pattier, S
    Gueffet, JP
    Redonnet, M
    Lelong, B
    Sirinelli, A
    Petit, T
    Treilhaud, M
    Trochu, JN
    EUROPEAN HEART JOURNAL, 2004, 25 : 500 - 500
12345